Half-year report · HY
4021.TEDINET S100X0X9
Period2025-04-01 → 2025-09-30
Filed2025-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥130.1bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥251.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥118.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥29.6bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥28.3bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥29.8bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥58.0bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥27.9bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥29.8bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥28.8bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥22.8bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥43.0bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥20.5bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥23.2bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥20.2bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥322.2bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥330.8bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥311.4bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥80.9bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥94.6bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥241.4bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥236.2bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥231.6bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥34.3bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥27.5bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥34.3bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥27.5bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥30.4bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥22.7bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥48.7bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥59.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥46.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥8.1bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥17.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥7.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥35.0bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥35.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥31.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥168.45 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥313.26 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥148.78 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 73.9% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.5% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.4% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 64
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2025-04-01 → 2025-09-30 | ¥14.8bn |
| Otherother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥6.8bn |
| Otherother segments | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥8.0bn |
| Otherother segments | segment profit | 2025-04-01 → 2025-09-30 | ¥789m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥61.9bn |
| Reconciling Itemsreconciling | revenue external | 2025-04-01 → 2025-09-30 | −¥12.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥49.4bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥3.1bn |
| Agricultural Chemical Productsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥42.3bn |
| Agricultural Chemical Productsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥36.7bn |
| Agricultural Chemical Productsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥5.6bn |
| Agricultural Chemical Productsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥12.0bn |
| Chemical Productsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥18.8bn |
| Chemical Productsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥12.5bn |
| Chemical Productsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥6.4bn |
| Chemical Productsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥97m |
| Functional Materialsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥54.4bn |
| Functional Materialsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥39.4bn |
| Functional Materialsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥15.0bn |
| Functional Materialsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥17.4bn |
| Healthcarereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥2.8bn |
| Healthcarereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥2.8bn |
| Healthcarereportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥48m |
| Healthcarereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥695m |
| Wholesalereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥58.8bn |
| Wholesalereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥44.4bn |
| Wholesalereportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥14.4bn |
| Wholesalereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥192.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥142.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥49.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥32.7bn |
| Otherother segments | revenue | 2024-04-01 → 2024-09-30 | ¥12.0bn |
| Otherother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥4.5bn |
| Otherother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥7.5bn |
| Otherother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥34m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥59.1bn |
| Reconciling Itemsreconciling | revenue external | 2024-04-01 → 2024-09-30 | −¥12.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥46.6bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥3.6bn |
| Agricultural Chemical Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥39.2bn |
| Agricultural Chemical Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥32.1bn |
| Agricultural Chemical Productsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥7.0bn |
| Agricultural Chemical Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥14.4bn |
| Chemical Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥17.9bn |
| Chemical Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥11.8bn |
| Chemical Productsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥6.0bn |
| Chemical Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥292m |
| Functional Materialsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥48.6bn |
| Functional Materialsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥36.0bn |
| Functional Materialsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥12.6bn |
| Functional Materialsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥14.5bn |
| Healthcarereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.3bn |
| Healthcarereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.2bn |
| Healthcarereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥74m |
| Healthcarereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.3bn |
| Wholesalereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥56.3bn |
| Wholesalereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥43.0bn |
| Wholesalereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥13.3bn |
| Wholesalereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥177.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥130.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥46.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥32.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 576
| Item | Context | Value | Unit |
|---|---|---|---|
| Net increase decrease in short term loans payable fin cf | InterimDuration | -8776000000 | JPY |
| Net increase decrease in commercial papers fin cf | Prior1InterimDuration | － | JPY |
| Net increase decrease in commercial papers fin cf | InterimDuration | -4997000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1InterimDuration | -317000000 | JPY |
| Repayment of long term loans payable fin cf | InterimDuration | -464000000 | JPY |
| Proceeds from issuance of bonds fin cf | Prior1InterimDuration | 10000000000 | JPY |
| Proceeds from issuance of bonds fin cf | InterimDuration | － | JPY |
| Cash dividends paid fin cf | Prior1InterimDuration | -13043000000 | JPY |
| Cash dividends paid fin cf | InterimDuration | -14187000000 | JPY |
| Dividends paid to non controlling interests fin cf | Prior1InterimDuration | － | JPY |
| Dividends paid to non controlling interests fin cf | InterimDuration | -105000000 | JPY |
| Purchase of treasury stock fin cf | Prior1InterimDuration | -5000000000 | JPY |
| Purchase of treasury stock fin cf | InterimDuration | -6499000000 | JPY |
| Other net fin cf | Prior1InterimDuration | -2000000 | JPY |
| Other net fin cf | InterimDuration | -9000000 | JPY |
| Net cash provided by used in financing activities | Prior1InterimDuration | -31087000000 | JPY |
| Net cash provided by used in financing activities | InterimDuration | -35041000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1InterimDuration | -325000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | InterimDuration | 1234000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1InterimDuration | 7694000000 | JPY |
| Net increase decrease in cash and cash equivalents | InterimDuration | 6819000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 22738000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 27454000000 | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | Prior1InterimDuration | 17000000 | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | InterimDuration | － | JPY |
| Cash and cash equivalents | Prior1InterimInstant | 30449000000 | JPY |
| Cash and cash equivalents | InterimInstant | 34274000000 | JPY |
| Transportation expenses oerwy | Prior1InterimDuration | 540000000 | JPY |
| Transportation expenses oerwy | InterimDuration | 581000000 | JPY |
| Personnel expenditure sga | Prior1InterimDuration | 9289000000 | JPY |
| Personnel expenditure sga | InterimDuration | 9983000000 | JPY |
| Retirement benefit expenses sga | Prior1InterimDuration | 318000000 | JPY |
| Retirement benefit expenses sga | InterimDuration | 279000000 | JPY |
| Provision for bonuses sga | Prior1InterimDuration | 1759000000 | JPY |
| Provision for bonuses sga | InterimDuration | 1840000000 | JPY |
| Experiment cost sga | Prior1InterimDuration | 2494000000 | JPY |
| Experiment cost sga | InterimDuration | 2829000000 | JPY |
| Depreciation sga | Prior1InterimDuration | 883000000 | JPY |
| Depreciation sga | InterimDuration | 2472000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E00759-000ChemicalProductsReportableSegmentsMember | 11850000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E00759-000FunctionalMaterialsReportableSegmentsMember | 36002000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E00759-000AgriculturalChemicalProductsReportableSegmentsMember | 32141000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E00759-000HealthcareReportableSegmentMember | 3220000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E00759-000WholesaleReportableSegmentsMember | 42955000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_OtherReportableSegmentsMember | 4526000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 130696000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReconcilingItemsMember | -12510000000 | JPY |
| Revenues from external customers | Prior1InterimDuration | 118185000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E00759-000ChemicalProductsReportableSegmentsMember | 6001000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E00759-000FunctionalMaterialsReportableSegmentsMember | 12608000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |